Compare BioNano Genomics Inc (BNGO) vs Crocs, Inc. (CROX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Crocs, Inc. — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Crocs, Inc. trades at $131.61 (market cap $6.31B). The key difference: Crocs, Inc. is far larger — about 461.9× BioNano Genomics Inc's market cap, and Crocs, Inc. is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | CROX | |
|---|---|---|
Market Cap | $13.66M | $6.31B |
Sector | Health | Consumer Staples |
52-Week High | $4.92 | $141.19 |
52-Week Low | $1.06 | $73.39 |
Enterprise Value | $16.26M | $7.83B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →
